Nanotech: FDA Seeks Input On Needed Device Tests, Defends Budget Request
This article was originally published in The Gray Sheet
Executive Summary
FDA will seek advice next month on the types of pre-clinical tests it should require for devices that incorporate nanotechnology
You may also be interested in...
FDA Biocompatibility Guidance Adds Nanotech, Absorbability Test Tips
A June 15 FDA final guidance on biological evaluation of devices adds new sections on biocompatibility testing compared to the 2013 draft version, including a risk-based approach to biocompatibility testing, as well as test article preparation recommendations for devices with submicron/nanotech components, in situ polymerizing or absorbable materials, and tips for chemical testing.
Regulatory News In Brief
HHS creates Recovery Act office: Office of Recovery Act Coordination will "enhance and streamline" HHS' efforts to manage $137 billion in funding granted under the economic stimulus package, according to a March 11 announcement. The new office will be led by Dennis Williams, a 20-year veteran of the department who also will become HHS deputy assistant secretary for recovery act coordination. As of March 11, HHS has distributed $3 billion in Recovery Act funds for programs like Medicaid and Community Health Centers. The stimulus bill was signed by President Obama in February (1"The Gray Sheet" Feb. 16, 2009, p. 3)
CDRH Urges Input As It Drafts Guidance On Devices Made With Nano Materials
Forthright feedback from industry could accelerate regulatory timelines for medical devices incorporating nanoscale materials, say FDA officials working to draft guidance on pre-market review of the devices